Log In
Print this Print this

Baxdela, Oral delafloxacin (RX-3341)

  Manage Alerts
Collapse Summary General Information
Company Melinta Therapeutics Inc.
DescriptionOral broad-spectrum fluoroquinolone antibiotic
Molecular Target DNA gyrase ; Topoisomerase IV
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today